BDBM355862 N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[1,2-b]pyridazin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridin-3-carboxamide::US9815840, Example 56
SMILES: CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnn3ccc(-c4cccc(CN(C)C)c4)c23)c(F)c1
InChI Key: InChIKey=FHJKDNGXXJCNKM-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM355862 (N-(4-((5-(3-((dimethylamino)methyl)phenyl)pyrrolo[...) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <40 | n/a | n/a | n/a | n/a | n/a | n/a |
The Asan Foundation US Patent | Assay Description The inhibitory effect of the compounds of the present invention on the activity of c-Met was confirmed as follows.Specifically, 250 μM G4Y1 pept... | US Patent US9815840 (2017) BindingDB Entry DOI: 10.7270/Q2862JQZ | |||||||||||
More data for this Ligand-Target Pair |